Tag Archives: Cosme Ordonez

ProMIS Neurosci (PMN) Receives a Buy from Noble Financial

A Wall Street analyst has provided a review for the Healthcare company today, but retained the same rating on the stock. Analyst Cosme Ordonez from Noble Financial remains bullish on ProMIS Neurosci (PMN – Research Report) and has a C$1

Genprex Inc (GNPX) Initiated with a Buy at Noble Financial

Noble Financial analyst Cosme Ordonez initiated coverage with a Buy rating on Genprex Inc (GNPX – Research Report) on April 26 and set a price target of $5. The company’s shares closed on Friday at $1.78, close to its 52-week

ProMIS Neurosci (PMN) Gets a Buy Rating from Noble Financial

In a new note to investors on February 14, an analyst has provided a rating update for ProMIS Neurosci (PMN – Research Report). The company received a Buy on February 14 from Noble Financial’s analyst Cosme Ordonez, with a C$1